Show simple item record

dc.contributor.authorKessler, Ute
dc.contributor.authorSchøyen, Helle Kristine
dc.contributor.authorAndreassen, Ole Andreas
dc.contributor.authorEide, Geir Egil
dc.contributor.authorHammar, Åsa
dc.contributor.authorMalt, Ulrik Fredrik
dc.contributor.authorØdegaard, Ketil Joachim
dc.contributor.authorMorken, Gunnar
dc.contributor.authorSundet, Kjetil Søren
dc.contributor.authorVaaler, Arne Einar
dc.date.accessioned2015-09-11T13:15:54Z
dc.date.accessioned2015-09-17T08:03:40Z
dc.date.available2015-09-11T13:15:54Z
dc.date.available2015-09-17T08:03:40Z
dc.date.issued2013
dc.identifier.citationBMC Psychiatry 2013, 13nb_NO
dc.identifier.issn1471-244X
dc.identifier.urihttp://hdl.handle.net/11250/300386
dc.description.abstractBackground: The literature on the neuropsychological profiles in Bipolar disorder (BD) depression is sparse. The aims of the study were to assess the neurocognitive profiles in treatment-resistant, acutely admitted BD depression inpatients, to compare the neurocognitive functioning in patients with BD I and II, and to identify the demographic and clinical illness characteristics associated with cognitive functioning. Methods: Acutely admitted BD I (n = 19) and BD II (n = 32) inpatients who fulfilled the DSM-IV-TR criteria for a major depressive episode were tested with the MATRICS Consensus Cognitive Battery (MCCB), the Wechsler Abbreviated Scale of Intelligence, the National Adult Reading Test, and a battery of clinical measures. Results: Neurocognitive impairments were evident in the BD I and BD II depression inpatients within all MCCB domains. The numerical scores on all MCCB-measures were lower in the BD I group than in the BD II group, with a significant difference on one of the measures, category fluency. 68.4% of the BD I patients had clinically significant impairment (>1.5 SD below normal mean) in two or more domains compared to 37.5% of the BD II patients (p = 0.045). A significant reduction in IQ from the premorbid to the current level was seen in BD I but not BD II patients. Higher age was associated with greater neurocognitive deficits compared to age-adjusted published norms. Conclusions: A high proportion of patients with therapy-resistant BD I or II depression exhibited global neurocognitive impairments with clinically significant severity. The cognitive impairments were more common in BD I compared to BD II patients, particularly processing speed. These findings suggest that clinicians should be aware of the severe neurocognitive dysfunction in treatment-resistant bipolar depression, particularly in BD I. Keywords: Bipolar disorder depression, Cognitive functioning, MATRICS, IQ, Bipolar II disordernb_NO
dc.language.isoengnb_NO
dc.publisherBioMed Centralnb_NO
dc.titleNeurocognitive profiles in treatment-resistant bipolar I and bipolar II disorder depressionnb_NO
dc.typeJournal articlenb_NO
dc.typePeer revieweden_GB
dc.date.updated2015-09-11T13:15:54Z
dc.subject.nsiVDP::Medisinske fag: 700::Klinisk medisinske fag: 750::Psykiatri, barnepsykiatri: 757nb_NO
dc.subject.nsiVDP::Midical sciences: 700::Clinical medical sciences: 750::Psychiatry, child psychiatry: 757nb_NO
dc.source.volume13nb_NO
dc.source.journalBMC Psychiatrynb_NO
dc.identifier.doi10.1186/1471-244X-13-105
dc.identifier.cristin1023736
dc.description.localcode© 2013 Kessler et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.nb_NO


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record